Salarius Pharmaceuticals (SLRX) Stock: Buy, Sell, or Hold?
SLRX - Salarius Pharmaceuticals, Inc. Common Stock
$0.84
0.19 (29.23%)
â˛
5d:
+29.71%
30d:
-0.01%
90d:
-81.42%
WAIT
LOW Confidence
Analysis Updated: Jan 7, 2026 12:00 AM ET
Get Alerted When SLRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SLRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SLRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SLRX is currently trading at $0.84, which is considered fair based on recent price action.
Technical Outlook: Technically, SLRX is in a strong downtrend. Immediate support is located at $0.51, while resistance sits at $0.90. The stock is showing strong short-term momentum, up 29.2% recently.
Market Sentiment: SLRX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $26.00 (+2995.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLRX is in a strong downtrend. Immediate support is located at $0.51, while resistance sits at $0.90. The stock is showing strong short-term momentum, up 29.2% recently.
Market Sentiment: SLRX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $26.00 (+2995.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
45/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+29.2%)
- BULLISH: Trading 2995.2% below Wall St target ($26.00)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$0.51
Resistance Level
$0.90
Current Trend
Strong Downtrend
Technical data as of
Jan 7, 2026
Fundamental Context
Wall Street Target
$26.00
(+2995.2%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: September 13, 2026 5:50 AM ET
Data refreshes hourly during market hours. Next update: 6:50 AM
Data refreshes hourly during market hours. Next update: 6:50 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 49 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
|
LRMR
Larimar Therapeutics Inc |
STRONG BUY
11 analysts |
$14 | 58 HOLD |
